-
公开(公告)号:ES2139673T3
公开(公告)日:2000-02-16
申请号:ES93921359
申请日:1993-09-03
Applicant: SEPRACOR INC
Inventor: WOOSLEY RAYMOND L , ABERG A K GUNNAR
IPC: C07D401/12 , A61K31/4427 , A61K31/445 , A61K31/4523 , A61K31/454 , A61K45/00 , A61K45/06 , A61P3/08 , A61P3/10 , A61P11/00 , A61P11/02 , A61P11/06 , A61P31/12 , A61P37/08 , A61P43/00
Abstract: Use of a composition comprising the compound of formula I: or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for use in a treatment of allergic rhinitis which does not induce any significant cardiac arrhythmia, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient.
-
公开(公告)号:AT187642T
公开(公告)日:2000-01-15
申请号:AT93921359
申请日:1993-09-03
Applicant: SEPRACOR INC
Inventor: WOOSLEY RAYMOND L , ABERG A K GUNNAR
IPC: C07D401/12 , A61K31/4427 , A61K31/445 , A61K31/4523 , A61K31/454 , A61K45/00 , A61K45/06 , A61P3/08 , A61P3/10 , A61P11/00 , A61P11/02 , A61P11/06 , A61P31/12 , A61P37/08 , A61P43/00
Abstract: Use of a composition comprising the compound of formula I: or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for use in a treatment of allergic rhinitis which does not induce any significant cardiac arrhythmia, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient.
-
公开(公告)号:AT162399T
公开(公告)日:1998-02-15
申请号:AT93918584
申请日:1993-08-03
Applicant: SEPRACOR INC , UNIV GEORGETOWN
Inventor: YOUNG JAMES W , GRAY NANCY M , WOOSLEY RAYMOND L , CHEN YIWANG
IPC: C07D211/22 , A61K9/48 , A61K31/137 , A61K31/165 , A61K31/192 , A61K31/445 , A61K31/451 , A61K31/60 , A61K45/00 , A61K45/06 , A61P17/00 , A61P27/16 , A61P37/08 , A61P43/00
Abstract: Use of a composition comprising a compound of formula I: or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in providing symptomatic relief from dermal irritation, wherein the induction of cardiac arrhythmia is avoided, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient whose hepatic function is not impaired.
-
公开(公告)号:DK0701443T3
公开(公告)日:1998-02-09
申请号:DK93918584
申请日:1993-08-03
Applicant: SEPRACOR INC , UNIV GEORGETOWN
Inventor: GRAY NANCY M , YOUNG JAMES W , WOOSLEY RAYMOND L , CHEN YIWANG
IPC: A61K9/48 , C07D211/22 , A61K31/137 , A61K31/165 , A61K31/192 , A61K31/445 , A61K31/451 , A61K31/60 , A61K45/00 , A61K45/06 , A61P17/00 , A61P27/16 , A61P37/08 , A61P43/00
Abstract: Use of a composition comprising a compound of formula I: or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in providing symptomatic relief from dermal irritation, wherein the induction of cardiac arrhythmia is avoided, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient whose hepatic function is not impaired.
-
公开(公告)号:CZ9500274A3
公开(公告)日:1996-09-11
申请号:CZ27495
申请日:1995-02-03
Applicant: SEPRACOR INC , UNIV GEORGETOWN
Inventor: YOUNG JAMES W , GRAY NANCY M , WOOSLEY RAYMOND L , CHEN YIWANG
IPC: C07D211/22 , A61K9/48 , A61K31/137 , A61K31/165 , A61K31/192 , A61K31/445 , A61K31/451 , A61K31/60 , A61K45/00 , A61K45/06 , A61P17/00 , A61P27/16 , A61P37/08 , A61P43/00
CPC classification number: A61K45/06 , A61K31/445 , A61K2300/00
-
公开(公告)号:ES2086270T1
公开(公告)日:1996-07-01
申请号:ES93918584
申请日:1993-08-03
Applicant: SEPRACOR INC
Inventor: YOUNG JAMES W , WOOSLEY RAYMOND L , GRAY NANCY M , CHEN YIWANG
IPC: A61K9/48 , C07D211/22 , A61K31/137 , A61K31/165 , A61K31/192 , A61K31/445 , A61K31/451 , A61K31/60 , A61K45/00 , A61K45/06 , A61P17/00 , A61P27/16 , A61P37/08 , A61P43/00
Abstract: Use of a composition comprising a compound of formula I: or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in providing symptomatic relief from dermal irritation, wherein the induction of cardiac arrhythmia is avoided, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient whose hepatic function is not impaired.
-
公开(公告)号:NO950374A
公开(公告)日:1995-03-29
申请号:NO950374
申请日:1995-02-01
Applicant: SEPRACOR INC , UNIV GEORGETOWN
Inventor: YOUNG JAMES W , GRAY NANCY M , WOOSLEY RAYMOND L , CHEN YIWANG
IPC: C07D211/22 , A61K9/48 , A61K31/137 , A61K31/165 , A61K31/192 , A61K31/445 , A61K31/451 , A61K31/60 , A61K45/00 , A61K45/06 , A61P17/00 , A61P27/16 , A61P37/08 , A61P43/00
CPC classification number: A61K45/06 , A61K31/445 , A61K2300/00
-
68.
公开(公告)号:HU9500313D0
公开(公告)日:1995-03-28
申请号:HU9500313
申请日:1993-08-03
Applicant: UNIV GEORGETOWN , SEPRACOR INC
Inventor: YOUNG JAMES W , GRAY NANCY M , WOOSLEY RAYMOND L , CHEN YIWANG
IPC: C07D211/22 , A61K9/48 , A61K31/137 , A61K31/165 , A61K31/192 , A61K31/445 , A61K31/451 , A61K31/60 , A61K45/00 , A61K45/06 , A61P17/00 , A61P27/16 , A61P37/08 , A61P43/00
Abstract: Use of a composition comprising a compound of formula I: or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in providing symptomatic relief from dermal irritation, wherein the induction of cardiac arrhythmia is avoided, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient whose hepatic function is not impaired.
-
公开(公告)号:AU6096094A
公开(公告)日:1994-08-15
申请号:AU6096094
申请日:1994-01-27
Applicant: SEPRACOR INC , UNIV GEORGETOWN
Inventor: GRAY NANCY M , WOOSLEY RAYMOND L
IPC: C07D405/14 , A61K31/495 , A61P31/04 , A61K31/50
Abstract: Methods and compositions are disclosed utilizing the optically pure (2R,4S) isomer of itraconazole. This compound is a potent drug for the treatment of local and systemic fungal, yeast, and dermatophyte infections, while avoiding the concomitant liability of adverse effects associated with the racemic mixture of itraconazole.
-
公开(公告)号:HU226242B1
公开(公告)日:2008-07-28
申请号:HU9500313
申请日:1993-08-03
Applicant: SEPRACOR INC
Inventor: YOUNG JAMES W , GRAY NANCY M , WOOSLEY RAYMOND L , CHEN YIWANG
IPC: A61K31/445 , A61K9/48 , C07D211/22 , A61K31/137 , A61K31/165 , A61K31/192 , A61K31/451 , A61K31/60 , A61K45/00 , A61K45/06 , A61P17/00 , A61P27/16 , A61P37/08 , A61P43/00
Abstract: Use of a composition comprising a compound of formula I: or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in providing symptomatic relief from dermal irritation, wherein the induction of cardiac arrhythmia is avoided, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient whose hepatic function is not impaired.
-
-
-
-
-
-
-
-
-